Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Marcoux

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cutaneous Medicine and Surgery|July 3, 2013
Therapy of ulcerated hemangiomasCatherine C McCuaig, Lynn Cohen, Julie Powell, et al.
Journal of Cutaneous Medicine and Surgery|June 23, 2017
Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus DocumentAfsaneh Alavi, Charles Lynde, Raed Alhusayen, et al.
Frontiers in Medicine|March 31, 2022
Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-IIStephanie Ghazal, Zainab Ridha, Kathleen D'Aguanno, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 9, 2025
Long-term outcomes of juvenile dermatomyositisValerie Hladky, Patrick Cyr, Julie Powell, et al.
Journal of Cutaneous Medicine and Surgery|May 22, 2010
Pyrethroid pediculicide resistance of head lice in Canada evaluated by serial invasive signal amplification reactionDanielle Marcoux, Kathleen G Palma, Nalini Kaul, et al.
Journal of the American Academy of Dermatology|June 1, 2019
Management of pediatric plaque psoriasis using biologicsPerla Lansang, James N Bergman, Loretta Fiorillo, et al.
Acta Dermato-Venereologica|May 27, 2021
Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant UseMette Deleuran, Danielle Marcoux, Marjolein S Bruin-Weller, et al.
Pediatric Dermatology|October 31, 2023
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumabSylvia Martinez-Cabriales, Danielle Marcoux, Carmen Liy-Wong, et al.
Pediatric Dermatology|March 7, 2013
Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendationsSébastien Barbarot, Claire Bernier, Mette Deleuran, et al.
Dermatology and Therapy|August 24, 2021
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and OlderEric L Simpson, Amy S Paller, Elaine C Siegfried, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cutaneous Medicine and Surgery|July 3, 2013
Therapy of ulcerated hemangiomasCatherine C McCuaig, Lynn Cohen, Julie Powell, et al.
Journal of Cutaneous Medicine and Surgery|June 23, 2017
Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus DocumentAfsaneh Alavi, Charles Lynde, Raed Alhusayen, et al.
Frontiers in Medicine|March 31, 2022
Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-IIStephanie Ghazal, Zainab Ridha, Kathleen D'Aguanno, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 9, 2025
Long-term outcomes of juvenile dermatomyositisValerie Hladky, Patrick Cyr, Julie Powell, et al.
Journal of Cutaneous Medicine and Surgery|May 22, 2010
Pyrethroid pediculicide resistance of head lice in Canada evaluated by serial invasive signal amplification reactionDanielle Marcoux, Kathleen G Palma, Nalini Kaul, et al.
Journal of the American Academy of Dermatology|June 1, 2019
Management of pediatric plaque psoriasis using biologicsPerla Lansang, James N Bergman, Loretta Fiorillo, et al.
Acta Dermato-Venereologica|May 27, 2021
Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant UseMette Deleuran, Danielle Marcoux, Marjolein S Bruin-Weller, et al.
Pediatric Dermatology|October 31, 2023
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumabSylvia Martinez-Cabriales, Danielle Marcoux, Carmen Liy-Wong, et al.
Pediatric Dermatology|March 7, 2013
Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendationsSébastien Barbarot, Claire Bernier, Mette Deleuran, et al.
Dermatology and Therapy|August 24, 2021
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and OlderEric L Simpson, Amy S Paller, Elaine C Siegfried, et al.
Pageof 6